We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APYX icon
151
Apyx Medical
APYX
$125M
$253K 0.02%
+48,544
New +$157K
LLY icon
152
CALL
Eli Lilly
LLY
$1.01T
$250K 0.02%
+1,000
New +$80K
NTLA icon
153
Intellia Therapeutics
NTLA
$1.59B
$250K 0.02%
14,673
-327
-2% -$6.33K
PMD
154
DELISTED
Psychemedics Corporation
PMD
$250K 0.02%
+12,626
New +$234K
ZGNX
155
DELISTED
Zogenix, Inc.
ZGNX
$212K 0.01%
+18,541
New +$171K
NSTG
156
DELISTED
NanoString Technologies, Inc.
NSTG
$210K 0.01%
+10,518
New +$167K
GKOS icon
157
Glaukos
GKOS
$10.1B
$200K 0.01%
5,300
+5,000
+1,667% +$165K
CGNT
158
DELISTED
Cogentix Medical, Inc.
CGNT
$180K 0.01%
99,008
-418,752
-81% -$542K
LHCG
159
DELISTED
LHC Group LLC
LHCG
$175K 0.01%
+4,745
New +$190K
ARAY icon
160
Accuray
ARAY
$27.5M
$174K 0.01%
+27,300
New +$149K
MTD icon
161
Mettler-Toledo International
MTD
$26.7B
$174K 0.01%
+415
New +$165K
NUVA
162
DELISTED
NuVasive, Inc.
NUVA
$173K 0.01%
+2,589
New +$165K
AMRI
163
DELISTED
Albany Molecular Research Inc
AMRI
$170K 0.01%
+10,300
New +$153K
MDSO
164
DELISTED
Medidata Solutions, Inc.
MDSO
$160K 0.01%
+2,865
New +$152K
IVC
165
DELISTED
Invacare Corporation
IVC
$147K 0.01%
+13,200
New +$159K
ISRG icon
166
Intuitive Surgical
ISRG
$133B
$145K 0.01%
+1,800
New +$138K
BOLD
167
DELISTED
Audentes Therapeutics, Inc
BOLD
$134K 0.01%
+7,500
New +$114K
HNGR
168
DELISTED
Hanger Inc.
HNGR
$128K 0.01%
+15,038
New +$128K
STRR
169
DELISTED
Star Equity Holdings
STRR
$127K 0.01%
500
– –
ATRC icon
170
AtriCure
ATRC
$2.86B
$126K 0.01%
+7,949
New +$122K
STML
171
DELISTED
Stemline Therapeutics, Inc.
STML
$116K 0.01%
10,702
-67,901
-86% -$552K
ACET
172
DELISTED
Aceto Corp
ACET
$115K 0.01%
+6,054
New +$137K
CYNO
173
DELISTED
Cynosure, Inc. Class A
CYNO
$92K 0.01%
+1,800
New +$93.5K
BMRN icon
174
BioMarin Pharmaceuticals
BMRN
$12.5B
$23K ﹤0.01%
+250
New +$23.5K
IMMU
175
DELISTED
Immunomedics Inc
IMMU
$17K ﹤0.01%
5,343
-216,357
-98% -$605K
5 6
7
8 9

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.